TOPFUND WHERE YOUR MONEY GROWS
Home / Stocks / Bilcare Ltd.
BI

Bilcare Ltd. Share Price

Live price, chart and which mutual funds hold this stock

TopFund Score: 33/100 · Weak See breakdown ↓
…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹100.72

Change

-2.05 (-1.99%)

Open

₹100.72

Prev. Close

₹102.77

Day High

₹100.72

Day Low

₹100.72

Volume Analysis

Traded

6,526

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (3)

  • •High debt-to-equity ratio (3.15)
  • •Low return on equity (1.39%)
  • •Below-average fundamentals quality score (33/100)

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹100.72 ₹100.72 ₹100.72 ₹100.72 ₹100.72 ₹100.72 ₹100.72
Fibonacci ₹100.72 ₹100.72 ₹100.72 ₹100.72 ₹100.72 ₹100.72 ₹100.72
Camarilla ₹100.72 ₹100.72 ₹100.72 ₹100.72 ₹100.72 ₹100.72 ₹100.72

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

—

1 Week

-7.74%

1 Month

+9.68%

3 Months

+61.64%

6 Months

—

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹37.06

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

-2.9%

Net margin -0.78% × asset turnover 0.87x × equity multiplier 4.28x

Company Overview

Sector

Healthcare

Market Cap

₹257 Cr

P/E (TTM)

12.9

ROE

1.39%

Book Value

₹83.6

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 23 Sep 2026. Not investment advice.

TopFund Analysis

Bilcare Ltd. scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 33/100. The strongest factor is Momentum (89/100), while Financial Strength (0/100) is the weakest area to weigh before deciding. Notably: High debt-to-equity ratio (3.15); low return on equity (1.39%).

TopFund Score — Fundamentals Quality

33/100 — Weak

Data confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

0

Growth

5

Valuation

50

Cash Flow

68

Corporate Governance

40

Momentum

89

Institutional Ownership

30

Business Quality

22

Risk & Volatility

51

Liquidity

0

From Screener.in

  • −Company has low interest coverage ratio.
  • −The company has delivered a poor sales growth of 3.33% over past five years.
  • −Promoter holding is low: 30.0%
  • −Company has a low return on equity of -2.83% over last 3 years.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 21 Sep 21 Sep
Announcement under Regulation 30 (LODR)-Newspaper Publication 7 Sep 07 Sep
Reg. 34 (1) Annual Report. 04 Sep

Board approved FY26 annual report and AGM on 26 Sep 2026; Mohan Bhandari, Kavita Bhansali appointments changed to 3 years.

Annual Report - 2025-26 4 Sep 04 Sep

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 182 190 175 200 194 202 198 194 186 178 181 188 226
Expenses + 169 173 158 208 175 194 187 186 175 175 168 171 189
Operating Profit 13 17 17 -8 19 8 11 8 11 3 13 17 37
OPM % 7.0% 9.0% 10.0% -4.1% 10.0% 3.8% 5.0% 4.0% 6.0% 1.9% 7.0% 9.0% 16.0%
Other Income + 3 1 4 9 4 -6 -6 21 6 4 3 12 0
Interest 19 20 21 23 21 24 19 19 19 19 17 18 18
Depreciation 10 10 11 13 12 11 12 5 12 12 5 5 4
Profit before tax -13 -13 -10 -35 -10 -33 -27 6 -13 -24 -6 7 15
Tax % -1.0% -5.0% 34.0% -44.0% 55.0% -10.0% -40.0% -119.0% -25.0% -1.0% 3.0% -13.0% -1.0%
Net Profit + -13 -12 -14 -20 -15 -30 -16 12 -10 -23 -6 8 15
EPS in Rs -3 -3 -3 -5 -3 -7 -3 7 -2 -5 0 6 5
Raw PDF — — — — — — — — — — — — —

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 2,692 2,603 2,633 2,778 2,997 1,827 623 845 982 747 788 734 773
Expenses + 2,506 2,396 2,443 2,617 2,827 1,782 572 784 925 708 742 689 703
Operating Profit 186 207 190 161 170 45 51 60 57 39 46 45 70
OPM % 7.0% 8.0% 7.0% 6.0% 6.0% 2.5% 8.0% 7.0% 6.0% 5.0% 6.0% 6.0% 9.0%
Other Income + 9 -87 107 297 59 254 45 44 237 16 12 26 20
Interest 236 151 176 249 283 174 76 69 60 82 83 72 72
Depreciation 191 164 177 416 378 239 46 39 38 45 18 20 26
Profit before tax -232 -194 -56 -207 -433 -114 -25 -4 196 -72 -43 -21 -7
Tax % -7.0% -58.0% 42.0% -4.0% 5.0% -13.0% -55.0% 3.0% 74.0% -18.0% -35.0% -19.0% —
Net Profit + -216 -82 -80 -199 -453 -99 -11 -4 50 -59 -28 -17 -6
EPS in Rs -92 -36 -36 -85 -193 -44 -9 -5 6 -14 0 1 6
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% —

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Reserves 1,073 689 590 376 -93 85 63 52 507 474 191 173
Borrowings + 2,311 2,122 2,014 2,089 2,270 707 677 690 639 756 689 620
Other Liabilities + 933 786 830 913 888 297 300 362 424 314 21 26
Total Liabilities 4,340 3,620 3,457 3,402 3,087 1,112 1,064 1,127 1,593 1,568 924 843
Fixed Assets + 1,926 2,432 2,403 2,180 2,005 534 494 465 1,045 1,038 456 432
CWIP 218 161 149 170 79 0 0 1 1 1 4 10
Investments 0 1 0 1 0 0 0 0 2 8 11 14
Other Assets + 2,196 1,026 904 1,051 1,003 577 570 661 545 521 453 387
Total Assets 4,340 3,620 3,457 3,402 3,087 1,112 1,064 1,127 1,593 1,568 924 843
Equity Capital 24 24 24 24 24 24 24 24 24 24 24 24

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + -315 177 300 98 206 256 72 41 -7 62 86 128
Cash from Investing Activity + 247 -358 -129 -203 -104 1,309 2 -4 36 -106 81 -5
Cash from Financing Activity + 119 149 -155 91 -103 -1,600 -83 -55 -19 36 -171 -132
Net Cash Flow 50 -32 16 -13 -1 -35 -9 -18 10 -7 -3 -10
CFO/OP -170 85 173 75 148 828 141 78 -6 162 192 283
Free Cash Flow -74 -12 165 -115 91 1,569 69 37 11 -34 142 120

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 30.01% → 30.01%
  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 69.94% 69.95% 69.95% 69.95% 69.95% 69.95% 69.95% 69.95% 69.94% 69.95% 69.95% 69.94%
Promoters 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01%
FII 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Bilcare Ltd. (this stock) 257 12.9 1.3 1.39%
Take Limited 229 38.9 7.38 16.5%
Nectar Lifesciences Ltd. 211 — 0.36 -31.3%
Lyka Labs Ltd. 310 — 3.31 -10.2%
Ambalal Sarabhai Ent L 316 22.2 2.0 12.4%
Brooks Lab Limited 180 13.7 1.47 22.0%
Nureca Limited 335 77.3 1.86 1.12%

Which Mutual Funds Hold Bilcare Ltd.?

Frequently Asked Questions about Bilcare Ltd.

Community Sentiment

What are other investors saying about Bilcare Ltd.?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.